JOURNALS & BOOKS IN CANCER RESEARCH 2013
www.iospress.com IOS PRESS JOURNAL PROGRAM
All IOS Press journals are published online and in print
Visit www.iospress.com to: • Enter your subscription online • Check all subscription options including backfiles • Purchase articles on a pay-per-view basis • Obtain a free electronic sample copy • Scan tables of contents • Set up a journal alert • Find complete Instructions for Authors
Open Library® : Open Access at IOS Press
In addition to publishing work in traditional subscription journals, IOS Press offers the option to publish research with open access, i.e. free to use, download, circulate and disseminate by everyone, wherever in the world, as long as proper attribution is given to the author and the original source. The Open Library® option is available to all authors and for all journals published by IOS Press.
IOS PRESS EBOOKS PROGRAM www.booksonline.iospress.com
• Place your order online for ebooks or hardcopy books • Browse tables of contents • Read abstracts and preliminary pages free of charge • Search by subject or book series • Buy single titles and gain immediate access • Become a member and gain full access to all titles
Follow us on Twitter: @IOSPress_STM JOURNALS
Analytical Cellular Pathology www.iospress.com/journal/analytical-cellular-pathology
Impact Factor: 0.917*
ISSN 2210-7177 (print) / ISSN 2210-7185 (online)
Analytical Cellular Pathology focuses on the burgeoning applications of physical techniques to the study of cells, tissues and organs in disease to elucidate pathogenesis and further translational research, enhanced diagnosis or prognostication, as well as new and better therapies. Of particular relevance are studies that explore the ways that aberrant biochemical and molecular pathways are transduced into the physical processes that underlie pathogenesis.
The journal appeals to an audience of pathologists, cell biologists and biochemists, as well as biomedical engineers by focusing on new applications of the rapidly evolving array of technologies. Papers should be based on novel concepts, novel methodologies or the novel use of existing methodologies that contribute to the study of pathologic processes, rather than methodological details only. Approaches include tools such as biomedical photonics, surface resonance phenomena and impedance tomography, as well as new approaches for ultra-high resolution magnetic resonance, multispectral, hyperspectral and vibrational mode analysis and computational biology models. Hypothesis generating and hypothesis- testing observational studies are also welcome. Brief History Editor-in-Chief Analytical Cellular Stanley Cohen, MD, University of Medicine & Dentistry of New Jersey, Pathology was New Jersey Medical School, Newark, NJ, USA launched in 1988, Email: [email protected] changed its name to Cellular Oncology Coordinating Editor between 2005 and Marion C. Cohen, PhD, SUNY Downstate Medical Center, Brooklyn, NY, USA 2009 and then in Email: [email protected] 2010, reverted to Analytical Cellular Associate Editors Pathology: Cellular Ulysses J. Balis, USA Richard Levenson, USA Oncology. Since 2011 Elaine Bearer, USA Jonathan Reichner, USA it has continued as Hilary Coller, USA Thomas Ried, USA Analytical Cellular Walter Giaretti, Italy Gordon W. Stamp, United Kingdom Pathology. Ronald H. Goldfarb, USA Ronald S. Weinstein, USA Abstracting & Indexing Coverage Academic Source Complete, Biochemistry & Biophysics Citation Index, Biological Abstracts, BIOSIS Previews, CAB Abstracts, Chemical Abstracts Service (CAS), Current Contents/Clinical Medicine, Current Contents®/ Life Sciences, EBSCO Databases, Elsevier BIOBASE, Embase, Global Health, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubMed, Science Citation Index Expanded (SciSearch®), Science Citation Index® (*Wos), Scopus, SIIC Data Bases Instructions for Authors www.iospress.com/journal/analytical-cellular-pathology/?tab=submission-of- manuscripts Subscription Information 2013 Volume 36 (6 issues) Institutional subscription (online only): US$995 / €715 Institutional subscription (print only): US$1079 / €775 *Journal Impact Factors from (including postage and handling) Journal Citation Reports® Science Edition 2011, published Institutional subscription (print and online): US$1278 / €918 by Thomson Reuters ©2012 (including postage and handling) Individual subscription (online only): US$250 / €210 Breast Disease An International Journal www.iospress.com/journal/breast-disease
ISSN 0888-6008 (print) / ISSN 1558-1551 (online)
The recent expansion of work in the field of breast cancer inevitably will hasten discoveries that will impact patient outcome. This research, that spans basic science, clinical medicine, epidemiology and public policy, poses difficulties for investigators. Not only is it necessary to be facile in comprehending ideas from many disciplines, but also, it is important to understand the public implications of these discoveries.
Breast Disease publishes review issues devoted to in-depth analyses of the scientific and public implications of recent research on a specific problem in breast cancer. Meeting the information needs of scientists, clinicians and policy makers, the reviews not only discuss recent discoveries, but also reflect on their impact in breast cancer research or clinical management.
Breast Disease now also publishes unsolicited peer-reviewed articles. Topics can cover basic cellular and molecular biology, epidemiology, genetics, clinical research, imaging and social and legal issues.
Editor-in-Chief Jeffrey E. Green, MD, Bethesda, MD, USA Email: [email protected]
Founding Editor Edison T. Liu, MD, Executive Director, Genome Institute of Singapore
Abstracting & Indexing Coverage Academic Source Complete, Cancer Prevention and Control Database, Chemical Abstracts Service (CAS), EBSCO Databases, Elsevier BIOBASE, Embase, Epilepsy Education and Prevention Database, Health Education and Promotion Database, Index Medicus, MEDLINE, Prenatal Smoking Cessation Database, PubMed, Scopus
Instructions for Authors www.iospress.com/journal/breast-disease/?tab=submission-of- manuscripts
Subscription Information 2013 Volume 34 (4 issues) Institutional subscription (online only): US$590 / €420 Institutional subscription (print only): US$646 / €460 (including postage and handling) Institutional subscription (print and online): US$764 / €544 (including postage and handling) Individual subscription (online only): US$175 / €150 Cancer Biomarkers www.iospress.com/journal/cancer-biomarkers
Impact Factor: 1.078*
ISSN 1574-0153 (print) / ISSN 1875-8592 (online)
Concentrating on molecular biomarkers in cancer research, Cancer Biomarkers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identification of markers associated with the disease processes, whether or not they are an integral part of the pathological lesion. The disease markers may include, but are not limited to, genomic, epigenomic, proteomics, cellular and morphologic and genetic factors predisposing to the disease or indicating the occurrence of the disease. Manuscripts on these factors or biomarkers, either in altered forms, abnormal concentrations or with abnormal tissue distribution leading to disease causation, are accepted.
Editor-in-Chief Sudhir Srivastava, PhD, MPH, National Cancer Institute, NIH, Bethesda, MD, USA Email: [email protected]
Associate Editors William E. Grizzle, MD, PhD Special Issues 2013 Anna Lokshin, PhD Beta-blockers in Attila T. Lorincz, PhD Cancer Paola Muti, MD Guest Editor: Karin D. Rodland, PhD Dr. Amal Melhem- Tesshi Yamada, MD, PhD Bertrand Abstracting & Indexing Coverage Biomarker Academic Source Complete, Biological Abstracts, BIOSIS Previews, Discordance in CAB Abstracts, Chemical Abstracts Service (CAS), Elsevier Breast Cancer BIOBASE, Embase, EMBIO, Journal Citation Reports/Science Guest Editors: Edition, MEDLINE, Prous Science Integrity, PubsHub, Science Naoto T. Ueno and Citation Index Expanded (SciSearch®), Scopus Naoki Niikura MiRNAs in Cancer: Instructions for Authors Non-coding RNAs www.iospress.com/journal/cancer-biomarkers/?tab=submission- as Appealing of-manuscripts Biomarkers for Malignancy Subscription Information 2013 Guest Editor: Volumes 13-14; 12 issues Pier Jr. Morin Institutional subscription (online only): US$1485 / €1090 Institutional subscription (print only): US$1653 / €1210 Cancer Biomarkers (including postage and handling) in Romenia: Institutional subscription (print and online): US$1950 / €1428 Realities and (including postage and handling) Perspectives Individual subscription (online only): US$300 / €250 Guest Editors: Ioana Berindan Neagoe and Angelo Paradiso
*Journal Impact Factors from Journal Citation Reports® Science Edition 2011, published by Thomson Reuters ©2012 Disease Markers www.iospress.com/journal/disease-markers
Impact Factor: 1.642*
ISSN 0278-0240 (print) / ISSN 1875-8630 (online)
Disease Markers publishes original research findings (and reviews solicited by the Editor-in-Chief) on the identification of markers associated with the disease processes, whether or not they are an integral part of the pathological lesion. The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or with abnormal tissue distribution. This journal is designed to provide a forum for publications dealing with original observations in this developing field on any aspect of the general topic including:
• Identification of new genetic or non-genetic markers (e.g., cell-surface antigens, serum proteins, intra- and extra-cellular enzymes, cytogenic markers and DNA- sequences) • Population studies of new and existing markers, designed to elucidate information on their normal distribution as well as that in disease states • Amplification of knowledge about existing markers • Family studies of markers in disease • New techniques for identification and/or isolation of important marker molecules • Use of monoclonal antibodies for the definition of molecular structures associated with disease markers • Identification of disease-associated abnormalities in DNA using recombinant DNA techniques, gene-cloning and DNA restriction enzyme fragment polymorphisms • Identification of markers identifying malignantly transformed neoplastic cells Special Issue 2013 Glycomics Editor-in-Chief Guest Editor: Sudhir Srivastava, PhD, MPH, National Cancer Institute, NIH, Bethesda, MD, USA Pamela Marino Email: [email protected]
Associate Editor Michele Carbone, MD, PhD
Abstracting & Indexing Coverage Academic Source Complete, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, CAB Abstracts, Chemical Abstracts Service (CAS), CSA Illumina, EBSCO Databases, Elsevier BIOBASE, Embase, EMBIO, Global Health, Index Copernicus, Journal Citation Reports/Science Edition, MEDLINE, Prous Science Integrity, PubMed, Reference Update®, Science Citation Index Expanded (SciSearch®), Scopus
Instructions for Authors www.iospress.com/journal/disease-markers/?tab=submission-of-manuscripts
Subscription Information 2013 Volumes 34-35; 12 issues Institutional subscription (online only): US$2150 / €1530 Institutional subscription (print only): US$2318 / €1650 (including postage and handling) *Journal Impact Factors from Institutional subscription (print and online): US$2748 / €1956 Journal Citation Reports® Science Edition 2011, published (including postage and handling) by Thomson Reuters ©2012 Individual subscription (online only): US$300 / €250 Human Antibodies www.iospress.com/journal/human-antibodies
ISSN 1093-2607 (print) / ISSN 1875-869X (online)
Human Antibodies is an international journal designed to bring together all aspects of human hybridomas and antibody technology under a single, cohesive theme. This includes fundamental research, applied science and clinical applications. Emphasis is on antisera, monoclonal antibodies, fusion partners, EBV transformation, transfections, in vitro immunization, defined antigens, tissue reactivity, scale-up production, chimeric antibodies, autoimmunity, natural antibodies/immune response, anti-idiotypes and hybridomas secreting interesting growth factors. Immunoregulatory molecules, including T cell hybridomas, are also featured.
Editor-in-Chief Mark C. Glassy, PhD, Integrated Medical Sciences Association Foundation, San Diego, CA, USA Email: [email protected]
Abstracting & Indexing Coverage Academic Source Complete, Article@inist, Biological Abstracts, BIOSIS Previews, Cambridge Scientific Abstracts, Chemical Abstracts Service (CAS), CSA Illumina, EBSCO Databases, Embase, Index Medicus, MEDLINE, PubMed, Scopus, SUBIS Special Issue 2013 Immune Response Instructions for Authors in Cancer Patients www.iospress.com/journal/human-antibodies/?tab=submission-of- Guest Editor: manuscripts Rishab Gupta Subscription Information 2013 Volume 22; 4 issues Institutional subscription (online only): US$740 / €545 Institutional subscription (print only): US$796 / €585 (including postage and handling) Institutional subscription (print and online): US$944 / €694 (including postage and handling) Individual subscription (online only): US$185 / €155 Books
New Approaches to Cell and Tissue Imaging: Pathology at the Crossroads
Editor: Stanley Cohen February 2013, approx. 500 pages, hardcover
The evolution of anatomic pathology from a discipline based upon direct observation of visual light images to whole spectrum multi-modality computer-intensive analysis is entering a phase of accelerated growth. However, the technologic base is expanding more rapidly than our ability to exploit it for diagnostic and experimental pathology. While the theoretical and practical underpinnings of the new technology are complex, the underlying principles are quite simple. Energy interactions with a biological specimen basically only involve four kinds of interactions: absorption, reflection, scatter and secondary emission. This holds true, for example, for both a radio wave perturbing aligned molecular dipoles or UV light shining at a slide. Radiologists have been quicker than pathologists at exploiting this generalization. The reasons for this may be found in the pixel level complexity of a microscopic slide as compared to a typical radiological image. The aim in pathology is reconstructing images from the data with resolution good enough for morphologic analysis at the cellular and tissue level, whereas the aim in radiology is to get enough visualization to identify the lesion or location of a biochemical event. Paradoxically, modern radiology deals with both ends of the spectrum; molecules and organs, while pathologists remain focused (pun intended) on cells and tissue architecture, and study molecular events in that context.
The purpose of this book is to present some of the promising new image-based and related technologies for the study of visualization, characterization, and study of abnormal cells and tissues that have evolved over the past few years and to discuss their current and potential applications in experimental pathology and, where feasible, clinical pathologic diagnosis. Just as the flourishing of molecular biology has led to a paradigm shift that has rejuvenated our field, the convergence of biomedicine, bioengineering, and sophisticated new tools of mathematical analysis will move us towards a towards a more quantitative and analytic discipline.
The authors, all experts in the field, have described this technology in a manner accessible to an audience consisting of pathologists, cell biologists and biochemists as well as biomedical engineers, using their own research as well as literature review to provide descriptions and examples of the use of this new armamentarium. Inevitably, these approaches as well as new techniques for in situ molecular imaging that are outside the scope of this book, as well as evolving non-invasive radiological procedures for screening and diagnosis will lead to a convergence of pathology and radiology. Translational Pathology of Early Cancer
Editors: S. Srivastava and W.E. Grizzle March 2012, 568 pp., hardcover ISBN 978-1-61499-023-9 (print) ISBN 978-1-61499-024-6 (online) Price: US$239 / €156
The visual pathologic features of tumors have always been the critical parameters in determining tumor type, however, over the last several decades molecular analysis of tumors has played an increasing role in the diagnostic pathology of tumors. Thus, “molecular pathology” has gradually emerged as a discipline in pathology which exploits the use of nucleic acid based techniques.
The purpose of this Handbook is to discuss the principles and the application of selected existing methods of molecular pathology and its use in the detection of early cancer. It describes the molecular changes that characterize preinvasive neoplastic lesions, molecular targets for early detection, validation of molecular targets and areas of new diagnostic technology that show promise either for early detection of neoplasias or other medically important uses in cancer prevention and care. The book describes recent advances in proteomics, metabolomics, stem cells research, micro RNA and other posttranslational molecular modifications; all these will serve the pressing needs in the development of the practice of personalized medicine.
The book is divided into three sections that follow a sequence from basic mechanisms of tumor development, through the molecular and biological abnormalities found in common types of cancers, to the technologies that are most applicable to detecting these biologic alterations in precancerous lesions. Each chapter discusses the scientific underpinnings of the evolution and progression of tumors in order to enable clinicians and other professionals who manage cancer patients to better understand the disease at the molecular and genetic levels. PUBLISH YOUR RESEARCH RESULTS OR CONFERENCE PROCEEDINGS WITH IOS PRESS
IOS Press welcomes proposals for publishing textbooks, edited volumes, handbooks, conference proceedings, monographs and dissertations.
Proposals can be sent to [email protected], or you can fill in the form in the Authors’ Corner on www.iospress.com.
Why publish with IOS Press?
High visibility of the publication · Book is submitted to relevant scientific indexes · Inclusion in Google Book Search
Lenient copyright policy · Authors retain copyright to their articles · Manuscript versions may be posted freely on personal websites
Print and online publication · DOI registration for all articles · All book articles available as separately downloadable items · High quality print publication produced in the Netherlands
Clear guidelines for authors and editors · Guidelines can be found through the Authors’ Corner on www.iospress.com · Author templates for LaTeX or MSWord at author’s choice
Personal approach · Dedicated team of skilled publishing professionals · All books receive individual attention · Flexibility
Worldwide marketing and distribution · Books are available through all major booksellers including Amazon and Barnes & Noble · Sales offices and representatives on all continents
Permanent archiving is guaranteed through an arrangement with the Dutch Royal Library
To explore IOS Press books and the Authors’ Corner, visit www.iospress.com.
For ebooks, go to www.booksonline.iospress.com ORDER FORM
Order Online at www.iospress.com Select the title of your choice and click subscribe now. No shipping costs will be charged. Yes, I would like to order…
Please send me the following journals: ______
Please send me the following book: New Approaches to Cell and Tissue Imaging: Pathology at the Crossroads
Please send me the following book: Translational Pathology of Early Cancer
Please bill me (postage and handling charges will be added)
Please charge my credit card: American Express Euro/MasterCard Visa
Card #: ______
Security Code: ______Exp. Date: ______
VAT #: ______
Name: ______
Address: ______
City/State: ______Zip/Postal Code: ______Country: ______
Email: ______Fax: ______
Signature: ______Date: ______If you would like to order directly from IOS Press, please use one of the addresses below: IOS Press, Inc. IOS Press IOS Press 4502 Rachael Manor Drive Nieuwe Hemweg 6B c/o Accucoms US, Inc. Fairfax, VA 22032 1013 BG Amsterdam For North America Sales and USA The Netherlands Customer Service (Journals only) Tel: +1 703 323 5600 Tel: +31 20 688 3355 West Point Commons, Suite 201 Fax: +1 703 323 3668 Fax: +31 20 687 0019 Lansdale, PA 19446 [email protected] Email: [email protected] USA (Books only) Tel: +1 866 855 8967 Fax: +1 215 660 5042 Email: [email protected] Order from your local bookseller or usual supplier.
10/12 ABOUT IOS PRESS
For 25 years IOS Press has been serving the scientific community worldwide. IOS Press publishes approximately 120 new books each year and around 100 international journals, covering topics ranging from computer science and mathematics to medicine and the natural sciences. Many titles are listed in the most important abstracting databases, such as Thomson Reuters’ Journal Citation Reports, MEDLINE and Scopus.
Headquartered in Amsterdam with satellite offices in the USA, Germany, India and China, IOS Press has established several strategic co-publishing initiatives. Notable acquisitions included Delft University Press in 2005 and Millpress Science Publishers in 2008.
IOS Press journals are available through the highly-regarded MetaPress platform (http://iospress.metapress.com).
www.iospress.com